Next Biomedical Co.,Ltd. (KOSDAQ:389650)
76,000
+400 (0.53%)
At close: Mar 19, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 650.57 billion as of March 20, 2026. Its market cap has increased by 49.23% in one year.
Market Cap
650.57B
Enterprise Value
631.39B
Revenue
14.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
76,000.00
Market Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 650.57B, an increase of 242.78%. That is a compound annual growth rate of 117.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 650.57B | -11.30% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 441.37B |
| MEDIANA Co.,Ltd | 353.34B |
| L&K Biomed | 202.72B |
| SELVAS Healthcare | 112.39B |
| Remed | 100.60B |
| Neofect | 88.42B |
| Noul Co.,Ltd. | 81.50B |
| Hironic | 74.74B |